News
Recruitment for the FAIR PARK II study is now closed: The last patient has been enrolled on December 5th 2019
The FAIR-PARK II 6h annual meeting was held virtually on 22nd April 2021
The FAIR-PARK II 5th annual meeting was held in Paris, France on 26th June 2019.
The FAIR-PARK II 4th annual meeting was held in Lisbon, Portugal on 15th and 16th June 2018.
The FAIR-PARK II 3rd annual meeting was held in Amsterdam, Netherlands on 26th and 27th June 2017.
The FAIR-PARK II 2nd annual meeting was held in Berlin, Germany on 23-24 June 2016.
The FAIR-PARK II kick-off meeting was held in Lille, France on 4-5 May 2015.
Recruitment for the FAIR PARK II study is now open: The first patient has been enrolled in Lille's hospital on February 9th 2016
The final list of European expert centres for the clinical trial is available since October 2015.
The final version of the protocol, as released by competent authorities and ethic national committees is available since january 2016
Patient Recruitment Countdown
16th December 2019
Patients to be recruited
0
Patients recruited
372
The recruitment is now closed
The Independent Data and Safety Monitoring Board will provide independent, competent, and timely review of the data quality and of safety of the clinical trial.
| Title | Name | Organisation | Country | Image |
|---|---|---|---|---|
| Dr | Thavarak Ouk | Centre Hospitalier Regional et Universitaire de Lille | France | |
| Dr | Nardo Nardocci | Istitu Besta | Italy | |
| Dr | Gian Luca Forni | Ospedia Galliera | Italy | |
| Dr (PhD) | Michael Bubenheim | CHU-Hôpitaux de Rouen | France | |
| Dr (PhD) | Gianluca Trifirò | University of Messina & Erasmus Medical Center, Rotterdam | The Netherlands |  |
The Executive Committee is in charge of the day-to-day management of FAIR-PARK-II activities. It ensures that decisions are properly implemented and monitors the day-to-day progress of the work packages.
| WP | Organisation Name | Short Name | Name | Image |
|---|---|---|---|---|
| WP1 (Chairman) | Centre Hospitalier Regional et Universitaire de Lille | CHRUL | David Devos |  |
| WP1 (Co-leader) | Institut National de la Santé et de la Recherche Médicale | INSERM | Olivier Rascol |  |
| Project Manager | Centre Hospitalier Regional et Universitaire de Lille | CHRUL | Pauline Guyon |  |
| Project Manager | INSERM - Transfert SA | IT | Delphine Smagghe |  |
| WP2 Leader | Centre Hospitalier Regional et Universitaire de Lille | CHRUL | Dominique Deplanque |  |
| WP3 Leader | University of Newcastle upon Tyne | UNEW | David Burn |  |
| WP4 Leader | Medizinische Universitat Innsbruck | MUI | Werner Poewe |  |
| WP5 Leader | Philipps Universitat Marburg | PUM | Richard Dodel |  |
| WP6 Leader | Instituto de Medicina Molecular | IMM | Joaquim Ferreira |  |
Centre Hospitalier Regional et Universitaire de Lille, France
More Information
Project Coordinator:
Pauline Guyon (Project Manager)
Lucille Marguet (Clinical Research Assistant)
Alexandra Preau (Communications)
Caroline Moreau (Principal Investigator)
Luc Defrebvre (Principal Investigator)
Centre Hospitalier Regional et Universitaire de Lille, France
2 avenue Oscar Lambret
59000 Lille, France
Web: chru-lille.fr
European Clinical Research Infrastructure Network, Toulouse, France
Inserm, France
More Information
Principal Investigators:
Address:
Web: inserm.fr
Inserm Transfert SA, Paris, France
More Information
Project Managers:
Inserm Transfert SA
7 rue Watt
75013 Paris, France
Web: inserm-transfert.fr
Université Pierre et Marie Curie, Paris, France
Medizinische Universitat Innsbruck, Austria
More Information
Principal Investigator:
Address:
Web: i-med.ac.at
ApoPharma Inc., Toronto, Canada
Univerzita Karlova v Praze, Prague, Czech Republic
Eberhard Karls Universitaet Tuebingen, Germany
Philipps Universitat Marburg, Germany
More Information
Principal Investigator and WP5 leader:
Address:
Web: uni-marburg.de
Universitaet Ulm, Germany
Instituto de Medicina Molecular
Fundació privada Clínic per a la Recerca Biomèdica, Barcelona, Spain
Stichting Katholieke Universiteit, Nijmegen, The Netherlands
University of Newcastle upon Tyne, UK
More Information
Principal Investigator and WP3 leader
Address:
Web: ncl.ac.uk
Christian-Albrechts-Universtitat zu Kiel
Form 1
Form 2
Form 3
Form 4
FAIR PARK II
Conservative iron chelation as a disease modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomised clinical trial of deferiprone
Latest News Articles
Navigation
Contact Us
People
Scientific Coordinator: Prof David Devos
Project Manager (CHRUL): Pauline Guyon [email protected]
Senior Project Manager (IT): Delphine Smagghe [email protected]
Project Manager (IT): Stephanie Le Naour [email protected]
Addresses
Centre Hospitalier Regional et Universitaire de Lille (CHRUL), 2 avenue Oscar Lambret - 59037 Lille Cedex
Inserm-Transfert (IT), 7 rue de Watt - 75013 Paris, France
Lille CHRUL
Paris Inserm Transfert
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633190.
© FAIRPARK II 2015